Riskpilot← Back to searchSign inGet full accessADDvise Newco Med AB
ABActiveOrg 5566245212Grev Turegatan 30Leasing of intellectual property and similar products, except copyrighted works · NACE 7740Est. 20020 employees
Revenue 2024
SEK 7,8M
+15% vs 2023
EBITDA margin
-6.6%
-58% vs 2023
Equity ratio
28.8%
Financial strength
Net profit 2024
SEK 9,9M
+10% vs 2023
| Revenue | SEK 7,8M | +15% |
| EBITDA | SEK -514K | -58% |
| Net profit | SEK 9,9M | +10% |
| Total assets | SEK 534M | -44% |
| Equity | SEK 153,7M | -75% |
| Employees | 0 | — |
Legal name
ADDvise Newco Med AB
Org number
5566245212
Legal form
Aktiebolag
NACE code
7740 · Leasing of intellectual property and similar products, except copyrighted works
Founded
22 mars 2002
Share capital
SEK 201 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Dessutom har verkställande direktören rätt att teckna firman beträffande löpande förvaltningsåtgärder
Company purpose
Bolaget ska genom hel- eller delägda dotterbolag idka handel med och tillverka huvudsakligen medicinteknisk utrustning och produkter samt driva annan därmed förenlig verksamhet.
Address
Grev Turegatan 30
Phone
+4645184620
Email
info@addvisegroup.se
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 0 | 0 | 360 | 6 801 | 7 839 |
| Staff expenses | — | — | −0 | — | — |
| EBITDA | 319 | 338 | −209 | −324 | −514 |
| Depreciation & amort. | −0 | −0 | — | — | — |
| EBIT | 319 | 338 | −209 | −324 | −514 |
| Net financials | −32 | −31 | 5 | 9 299 | 9 621 |
| Profit before tax | 156 | 157 | −205 | 8 975 | 9 858 |
| Tax | −33 | −32 | — | — | −1 |
| Net profit | 123 | 125 | −205 | 8 975 | 9 857 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 12 354 | 1 770 | 1 512 | 961 548 | 534 010 |
| Equity | 1 567 | 1 692 | 1 487 | 616 325 | 153 671 |
| Long-term debt | 0 | 0 | — | — | — |
| Short-term debt | 10 788 | 78 | 25 | 345 223 | 380 339 |
| Total debt | 10 788 | 78 | 25 | 345 223 | 380 339 |
EBITDA margin
-6.6%
This company
15.8%
Market median
-142% vs market
20202024
Equity ratio
28.8%
This company
38.2%
Market median
-25% vs market
20202024
Return on equity
6.4%
This company
18.4%
Market median
-65% vs market
20202024
Net profit margin
125.7%
This company
8.1%
Market median
+1452% vs market
20202024
Asset turnover
0.01×
This company
1.12×
Market median
-99% vs market
20202024
Debt / equity
2.48×
This company
0.62×
Market median
-300% vs market
20202024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
PJ Chief Auditor | Chief Auditor | 2020 |
| Former (3) | ||
HE Chief Executive Officer | Chief Executive Officer | 2020 – 2021 |
MI Chief Auditor | Chief Auditor | 2022 – 2023 |
RA Chief Executive Officer | Chief Executive Officer | 2022 – 2024 |
| Name | Role | Member since |
|---|---|---|
| Current (3) | ||
| Deputy Board Member | 2025 | |
| Board of Directors | 2025 | |
| Chairman | 2024 | |
| Former (3) | ||
| Chairman | 2022 – 2023 | |
| Board of Directors | 2020 – 2024 | |
| Board of Directors | 2022 – 2023 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 100% | 100% | 2024 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Addvise Group Ab (Publ)
ADDvise Newco Med AB Board members of ADDvise Newco Med AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Hans Erland Ivan Pontusson | Chief Executive Officer | 0 companies |
| Magnus Ivar Thorling | Chief Auditor | 0 companies |
| Rikard Akhtarzand | Chief Executive Officer | 0 companies |
| Per Johan Engstam | Chief Auditor | 0 companies |
| Jonas Fredrik Mella | Chairman | 0 companies |
| Oliver Humlen | Board of Directors | 0 companies |
| Hanna Rebecca Lovisa Myhrman | Deputy Board Member | 0 companies |
| Jakob Sebastian Rutger af Robson | Board of Directors | 0 companies |
| Johan Magnus Irwe | Board of Directors | 0 companies |
| Erik Staffan Bernstein Torstensson | Chairman | 0 companies |